舒脉降压汤联合替米沙坦治疗高血压的临床疗效
CSTR:
作者:
作者单位:

(开封市祥符区第二人民医院,河南 开封 475121)

作者简介:

马孝辉,男,主治医师,主要从事内科临床工作。

通讯作者:

中图分类号:

R 544.1

基金项目:


Clinical Effect of Shumai Jiangya Decoction Combined with Telmisartan in the Treatment of Hypertension
Author:
Affiliation:

(Xiangfu District Second People's Hospital of Kaifeng City, Henan Kaifeng 475121)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:分析在高血压的治疗过程中使用舒脉降压汤联合替米沙坦治疗的临床效果。方法:选取开封市祥 符区第二人民医院 2019 年 1 月至 2019 年 10 月期间收治的 140 例高血压患者,随机均分为对照组与观察组,各 70 例。 对照组给予患者替米沙坦片治疗,观察组给予患者舒脉降压汤联合替米沙坦治疗。比较两组患者治疗效果。结果: 观察组患者治疗总有效率为 90.00 %,高于对照组的 65.71 %,差异具有统计学意义(P < 0.05)。治疗后观察组患者 的收缩压、舒张压均低于对照组,差异具有统计学意义(P < 0.05)。治疗后观察组患者的同型半胱氨基酸(Hcy)、 C 反应蛋白(CRP)、低密度脂蛋白胆固醇(LDL–C)均低于对照组,差异具有统计学意义(P < 0.05)。治疗后观 察组患者的中医症状积分均低于对照组,差异具有统计学意义(P < 0.05)。观察组患者不良反应发生率为 30.00 %, 低于对照组的 31.43 %,但差异无统计学意义(P > 0.05)。结论:在高血压的治疗过程中使用舒脉降压汤联合替米 沙坦治疗的临床效果显著。

    Abstract:

    〔Abstract〕Objective To study and analyze the effect of Shumai Jiangya decoction combined with telmisartan in the treatment of hypertension. Methods A total of 140 hypertensive patients admitted to Xiangfu District Second People's Hospital of Kaifeng City from January 2019 to October 2019 were selected and randomly divided into a control group and an observation group, with 70 cases in each group. The control group was given telmisartan tablets, and the observation group was given shumai jiangya decoction combined with telmisartan. The treatment effects of the two groups of patients were compared. Results The total effective rate of the observation group was 90.00 %, higher than 65.71 % of the control group, the difference was statistically significant (P < 0.05). After treatment, systolic blood pressure and diastolic blood pressure in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). After treatment, the levels of homocysteine (Hcy), C-reactive protein (CRP) and low-density lipoprotein cholesterol (LDL-C) in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). After treatment, the scores of traditional Chinese medicine (TCM) symptoms in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). There was no difference in the incidence of adverse reactions in the observation group was 11.43%, lower than 31.43% in the control group (P > 0.05). Conclusion In the course of the treatment of hypertension, shumai jiangya decoction combined with telmisartan has a significant clinical effect.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-11-17
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-05-24
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭